Curaleaf Celebrates Opening Of Tamarac, Florida Dispensary

WAKEFIELD, Mass. – Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF), an international provider of consumer products in cannabis, announced the opening of its newest location in Tamarac, Florida. Curaleaf Tamarac is the Company’s 45th location in Florida and the second in Broward County.

Located at 6899 N University Drive, Curaleaf Tamarac will expand medical cannabis access in the western half of the state’s second most-populated county. Patients can choose from a wide variety of high-quality products including Select Nano Bites, Select Squeeze, Select Bites as well as the Company’s proprietary gravity-fed vape pod, Cliq by Select. Last week, Select’s first solventless product, Select Live Rosin vapes began rolling out across the state. Curaleaf first began serving Broward County in 2018 through its Deerfield Beach location, however this new location is Curaleaf’s first location in West Broward County.

Curaleaf continues to scale its operations in the largest medical market in the U.S. Using a tailored retail approach rooted in patient education and advocacy, the Company has served nearly 300,000 patients through its 45 dispensaries across Florida. Curaleaf’s recent momentum has doubled its Florida market share over the last year.

“We are excited to deepen our roots in the Sunshine State and serve even more patients in Broward County,” said Matt Darin, President of Curaleaf US. “Our team is grateful for the continued support of Florida’s medical cannabis community as we offer convenient and accessible patient experiences through our growing retail presence.”

To celebrate the grand opening of Curaleaf Tamarac, the Company will offer half-priced products and double rewards points beginning Friday, April 1 through Sunday, April 3. Prizes and gifts with purchases will also be offered on Friday, April 1st.

Forward Looking Statements
This media advisory contains forward–looking statements and forward–looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as “plans”, “expects” or, “proposed”, “is expected”, “intends”, “anticipates”, or “believes”, or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward–looking statements and information concerning the opening of a new dispensary in Tamarac, Florida. Such forward-looking statements and information reflect management’s current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and risks and uncertainties is contained under “Risk Factors and Uncertainties” in the Company’s latest annual information form filed March 9, 2022 which is available under the Company’s SEDAR profile at http://www.sedar.com, and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward looking statements contained in this press release. The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.

(This information is primarily sourced from Curaleaf Holdings, Inc.  Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).